Oncology Institute, Inc. - TOI
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | — | P | A | 33,500.0 | 4.07 | 136,345.0 | 10,567,858.0 | View | |
| May 21, 2026 | — | P | A | 5,000.0 | 4.05 | 20,250.0 | 10,534,358.0 | View | |
| May 20, 2026 | — | P | A | 30,000.0 | 4.09 | 122,700.0 | 10,529,358.0 | View | |
| Apr 16, 2026 | — | S | D | 38,433.0 | 3.5005 | 134,534.72 | 172,583.0 | View | |
| Apr 16, 2026 | — | S | D | 57,286.0 | 3.5017 | 200,598.39 | 211,016.0 | View | |
| Apr 13, 2026 | — | P | A | 20,000.0 | 3.1 | 62,000.0 | 10,499,358.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | J | D | 20,320.0 | 3.07 | 62,382.4 | 416,405.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | A | D | 202,914.0 | 0.0 | 0.0 | 436,725.0 | View | |
| Apr 01, 2026 | Chief Medical Officer | J | D | 16,173.0 | 3.07 | 49,651.11 | 284,783.0 | View | |
| Apr 01, 2026 | Chief Medical Officer | A | A | 66,446.0 | 0.0 | 0.0 | 300,956.0 | View | |
| Apr 01, 2026 | Chief Administrative Officer | A | A | 55,743.0 | 0.0 | 0.0 | 153,780.0 | View | |
| Apr 01, 2026 | Chief Clinical Officer | A | A | 70,270.0 | 0.0 | 0.0 | 127,650.0 | View | |
| Apr 01, 2026 | Chief Executive Officer | J | D | 98,534.0 | 3.07 | 302,499.38 | 2,360,224.0 | View | |
| Apr 01, 2026 | Chief Executive Officer | A | D | 670,608.0 | 0.0 | 0.0 | 2,458,758.0 | View | |
| Mar 30, 2026 | — | P | A | 27,429.0 | 2.96 | 81,189.84 | 10,479,358.0 | View | |
| Mar 27, 2026 | — | P | A | 50,000.0 | 3.15 | 157,500.0 | 10,451,929.0 | View | |
| Mar 25, 2026 | — | P | A | 125,000.0 | 3.11 | 388,750.0 | 10,401,929.0 | View | |
| Mar 23, 2026 | — | P | A | 25,000.0 | 3.35 | 83,750.0 | 10,276,929.0 | View | |
| Mar 18, 2026 | Chief Financial Officer | J | D | 1,314.0 | 3.59 | 4,717.26 | 233,811.0 | View | |
| Mar 18, 2026 | Chief Executive Officer | J | D | 11,834.0 | 3.59 | 42,484.06 | 1,788,150.0 | View | |
| Mar 18, 2026 | Chief Medical Officer | J | D | 3,420.0 | 3.59 | 12,277.8 | 234,510.0 | View | |
| Mar 17, 2026 | — | P | A | 75,000.0 | 3.42 | 256,500.0 | 10,251,929.0 | View | |
| Mar 17, 2026 | — | P | A | 60,985.0 | 3.29 | 200,640.65 | 10,176,929.0 | View | |
| Mar 17, 2026 | — | P | A | 263,000.0 | 2.92 | 767,960.0 | 10,115,944.0 | View | |
| Jan 06, 2026 | Chief Financial Officer | J | D | 244.0 | 3.67 | 895.48 | 235,125.0 | View | |
| Jan 05, 2026 | Chief Financial Officer | S | D | 247.0 | 3.56 | 879.32 | 235,122.0 | View | |
| Dec 16, 2025 | — | S | D | 13,333.0 | 3.7719 | 50,290.74 | 683,721.0 | View | |
| Nov 24, 2025 | — | A | A | 40,123.0 | 0.0 | 0.0 | 291,370.0 | View | |
| Nov 24, 2025 | — | A | A | 67,901.0 | 0.0 | 0.0 | 251,247.0 | View | |
| Nov 24, 2025 | — | A | A | 40,123.0 | 0.0 | 0.0 | 268,302.0 | View | |
| Nov 24, 2025 | — | A | A | 50,926.0 | 0.0 | 0.0 | 228,179.0 | View | |
| Nov 24, 2025 | — | A | A | 37,037.0 | 0.0 | 0.0 | 333,539.0 | View | |
| Nov 24, 2025 | — | A | A | 46,296.0 | 0.0 | 0.0 | 296,502.0 | View | |
| Nov 24, 2025 | — | A | A | 35,494.0 | 0.0 | 0.0 | 256,761.0 | View | |
| Nov 24, 2025 | — | A | A | 46,296.0 | 0.0 | 0.0 | 221,267.0 | View | |
| Nov 24, 2025 | — | A | A | 32,407.0 | 0.0 | 0.0 | 697,054.0 | View | |
| Nov 24, 2025 | — | A | A | 41,667.0 | 0.0 | 0.0 | 664,647.0 | View | |
| Nov 24, 2025 | — | A | A | 37,037.0 | 0.0 | 0.0 | 288,286.0 | View | |
| Nov 24, 2025 | — | A | A | 47,840.0 | 0.0 | 0.0 | 251,249.0 | View |